Penserra Capital Management LLC - PEAR THERAPEUTICS INC ownership

PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 26 filers reported holding PEAR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.8%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of PEAR THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$5,000
-78.3%
3,379
-28.1%
0.00%
-100.0%
Q1 2022$23,000
-37.8%
4,699
-22.4%
0.00%0.0%
Q4 2021$37,0006,0520.00%
Other shareholders
PEAR THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Arboretum Ventures, Inc. 10,859,050$67,326,00038.78%
5AM Venture Management, LLC 18,631,771$115,517,00021.68%
TB Alternative Assets Ltd. 2,071,865$12,846,0003.80%
Palantir Technologies Inc. 1,000,000$6,200,0002.81%
SB Global Advisers Ltd 12,100,078$75,020,0001.49%
EDBI Pte Ltd 426,371$2,644,0001.44%
Temasek Holdings (Private) Ltd 26,803,573$166,182,0000.60%
Alpine Global Management, LLC 625,134$3,876,0000.57%
Blue Water Life Science Advisors, LP 194,686$1,207,0000.37%
Sarissa Capital Management LP 500,356$3,102,0000.27%
View complete list of PEAR THERAPEUTICS INC shareholders